389 related articles for article (PubMed ID: 19352085)
1. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
[TBL] [Abstract][Full Text] [Related]
3. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
[TBL] [Abstract][Full Text] [Related]
4. [Intravitreal chemotherapy for intraocular lymphoma].
Helbig H; Cerny T; de Smet MD
Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
[TBL] [Abstract][Full Text] [Related]
5. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
6. Primary intraocular lymphoma: improving the diagnostic procedure.
Karma A; von Willebrand EO; Tommila PV; Paetau AE; Oskala PS; Immonen IJ
Ophthalmology; 2007 Jul; 114(7):1372-7. PubMed ID: 17324466
[TBL] [Abstract][Full Text] [Related]
7. [Malignant lymphoma of the central nervous system and eye].
Tropinskaia OF; Serova NK; Aronov MS; Kobiakov GL
Vestn Oftalmol; 2008; 124(1):14-9. PubMed ID: 18318202
[TBL] [Abstract][Full Text] [Related]
8. Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice.
Mineo JF; Scheffer A; Karkoutly C; Nouvel L; Kerdraon O; Trauet J; Bordron A; Dessaint JP; Labalette M; Berthou C; Labalette P
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4738-45. PubMed ID: 18552383
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-related primary central nervous system lymphoma after cadaveric renal transplantation improved by treatment with high-dose methotrexate followed by irradiation.
Higuchi M; Hata T; Furuya S; Hosaka S; Kamijo Y; Kiyosawa K; Ishizuka O; Nishizawa O; Hora K
Nephrology (Carlton); 2005 Jun; 10(3):321-4. PubMed ID: 15958050
[TBL] [Abstract][Full Text] [Related]
10. [Intraocular lymphoma associated with primary malignant lymphoma of the central nervous system: Seven-year experience of a tertiary center].
Joubert R; Bonnin N; Kemeny JL; Moluçon-Chabrot C; Tournilhac O; Bacin F; Chiambaretta F
J Fr Ophtalmol; 2015 Jun; 38(6):559-66. PubMed ID: 25976140
[TBL] [Abstract][Full Text] [Related]
11. Severe complications after intrathecal methotrexate (MTX) for treatment of primary central nervous system lymphoma (PCNSL).
Weigel R; Senn P; Weis J; Krauss JK
Clin Neurol Neurosurg; 2004 Mar; 106(2):82-7. PubMed ID: 15003295
[TBL] [Abstract][Full Text] [Related]
12. Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.
Velez G; Boldt HC; Whitcup SM; Nussenblatt RB; Robinson MR
Ophthalmic Surg Lasers; 2002; 33(4):329-33. PubMed ID: 12134997
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.
Mason JO; Fischer DH
Ophthalmology; 2003 Jun; 110(6):1241-4. PubMed ID: 12799254
[TBL] [Abstract][Full Text] [Related]
14. High-dose methotrexate for intraocular lymphoma.
Batchelor TT; Kolak G; Ciordia R; Foster CS; Henson JW
Clin Cancer Res; 2003 Feb; 9(2):711-5. PubMed ID: 12576439
[TBL] [Abstract][Full Text] [Related]
15. [A case of intraocular lymphoma having retinal adverse events associated with intravitreal methotrexate].
Kuroiwa N; Abematsu N; Matsuo Y; Nakao K; Sakamoto T
Nippon Ganka Gakkai Zasshi; 2011 Jul; 115(7):611-6. PubMed ID: 21815491
[TBL] [Abstract][Full Text] [Related]
16. Treatment of primary intraocular lymphoma (PIOL) has involved systemic, intravitreal or intrathecal chemotherapy and/or radiotherapy.
Itty S; Olson JH; O'Connell DJ; Pulido JS
Retina; 2009 Mar; 29(3):415-6. PubMed ID: 19174721
[No Abstract] [Full Text] [Related]
17. [Diagnostic problems in case of primary central nervous system lymphoma].
Dubik-Jezierzańska M; Pokryszko-Dragan A; Turek T; Budrewicz S; Pawlik B
Wiad Lek; 2006; 59(7-8):552-6. PubMed ID: 17209358
[TBL] [Abstract][Full Text] [Related]
18. [Two cases of primary intracerebral malignant lymphoma (author's transl)].
Kubota S; Hashimoto T; Kubo O; Hamada H; Pkino T
No Shinkei Geka; 1975 Jan; 3(1):67-73. PubMed ID: 1105227
[TBL] [Abstract][Full Text] [Related]
19. [An autopsy case of primary central nervous system lymphoma with diffuse intracerebral lesion].
Kazahaya Y; Doi A; Hamaya K
No To Shinkei; 1992 Jan; 44(1):65-70. PubMed ID: 1562388
[TBL] [Abstract][Full Text] [Related]
20. [Primary intraocular lymphoma with unusual clinical presentation and poor outcome].
Pache M; Kain H; Buess M; Flammer J; Meyer P
Klin Monbl Augenheilkd; 2004 May; 221(5):401-3. PubMed ID: 15162291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]